Risk Estimation of Metabolic Syndrome at One and Three Years After a Pregnancy Complicated by Preeclampsia

Journal of Obstetrics and Gynaecology Canada

Volumn 34, Issue 9, 2012, Pages 836-841

  Smith, Graeme N ^a   Pudwell, Jessica ^a   Walker, Mark ^b   Wen, Shi Wu ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Metabolic syndrome; Pregnancy; Primary prevention; Screening

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN; ARABIDOPSIS PROTEIN; NUCLEAR PROTEIN; TIC PROTEIN, ARABIDOPSIS;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOMETABOLIC RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PREECLAMPSIA; PREGNANCY; PREVALENCE; PROSPECTIVE STUDY; PUERPERIUM; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; DIET RESTRICTION; PATHOPHYSIOLOGY;

ADULT; ARABIDOPSIS PROTEINS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; FASTING; FEMALE; HUMANS; LONGITUDINAL STUDIES; METABOLIC SYNDROME X; NUCLEAR PROTEINS; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84878881989     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)35382-8     Document Type: Article

References (20)

1. Smith G.C.S., Pell J.P., Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001, 357:2002-2006.
2. Smith G.N., Walker M., Liu A., Wen S.W., Swansburg M., Ramshaw H., et al. Pre-Eclampsia New Emerging Team (PE-NET). A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009, 58:1-58. e8.
3. Retnakaran R., Shah B.R. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 2009, 181:371-376.
4. Retnakaran R. Glucose tolerance status in pregnancy: a window to the future risk of diabetes and cardiovascular disease in young women. Curr Diabetes Rev 2009, 5:239-244.
5. Retnakaran R., Qi Y., Connelly P.W., Sermer M., Zinman B., Hanley A.J.G. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010, 95:670-677.
6. Ray J.G., Vermeulen M.J., Schull M.J., Redelmeier D.A. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005, 366:1797-1803.
7. Irgens H.U., Reisaeter L., Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001, 323:1213-1217.
8. Smith G.N. The development of pre-eclampsia provides a window of opportunity for early cardiovascular risk screening and intervention. Expert Rev Obstet Gynecol 2009, 4:355-357.
9. Mosca L., Benjamin E.J., Berra K., Bezanson J.L., Dolor R.J., Lloyd-Jones D.M., et al. American Heart Association. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update. J Am Coll Cardiol 2011, 57:1404-1423.
10. Kahn R., Buse J., Ferrannini E., Stern M. American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289-2304.
11. Smith G.N., Pudwell J., Walker M., Wen S.-W. Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can 2012, 34:830-835.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
13. Grundy S.M., Hansen B., Smith S.C., Cleeman J.I., Kahn R.A. for Conference Participants. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung and Blood Institute/ American Diabetes Association conference on scientific issues related to management. Circulation 2004, 109:551-556.
14. Funai E.F., Paltiel O.B., Malaspina D., Friedlander Y., Deutsch L., Harlap S. Risk factors for pre-eclampsia in nulliparous and parous women: the Jerusalem Perinatal Study. Paediatr Perinat Epi 2005, 19:59-68.
15. Roberts J.M., Gammill H. Pre-eclampsia and cardiovascular disease in later life. Lancet 2005, 366:961-962.
16. Lloyd-Jones D. Short-term versus long-term risk for coronary artery disease: implications for lipid guidelines. Curr Opin Lipidol 2006, 17:619-625.
17. Lee D.S., Chiu M., Manuel D.G., Tu K., Wang X., Austin P.C., et al. Canadian Cardiovascular Outcomes Research Team. Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors. CMAJ 2009, 181(3-4):55-66.
18. Tu K., Chen Z., Lipscombe L.L. Canadian Hypertension Education Program Outcomes Research Taskforce. Prevalence and incidence of hypertension from 1995 to 2005 a population-based study. CMAJ 2008, 178:1429-1435.
19. Heart and Stroke Foundation of Canada. A perfect storm of heart disease looming on our horizon: 2010 Heart and Stroke Foundation Annual Report on Canadians' Health. 1-8 2010, Available at, Accessed July 7, 2012. http://www.heartandstroke.com/atf/cf/99452D8B-E7F1-4BD6-A57D-B136CE6C95BF/Jan23_EN_ReportCard.pdf.
20. Smith E.R. Canadian heart health strategy and action plan: building a heart healthy Canada (CHHS-AP). 2010, Available at, Accessed July 5, 2011. http://www.chhs.ca.